Today's pre-market stock movers: GPS, JD, LI, SIVB and more

• $A10 Networks (ATEN.US)$ +10.6% (to join S&P SmallCap 600)

• $硅谷银行 (SIVB.US)$ +8.9% （earnings report）

• $Revance Therapeutics (RVNC.US)$ +8.9% (FDA accepts BLA resubmission for DaxibotulinumtoxinA for Injection)

• $UFP Industries (UFPI.US)$ +5.9% (also increases dividend)

• $京东 (JD.US)$ +3.8% (weighing payment of special cash dividend)

• $Establishment Labs (ESTA.US)$ +3.4% (Presentation of 2-Year Results from Motiva US IDE Study at The Aesthetic Meeting 2022)

• $美国史丹利公司 (SWK.US)$ +2.6% (sells Access Technologies Business to Allegion (ALLE) for $900 mln)

• $Carvana (CVNA.US)$ +2% (prices offering of 15,625,000 shares of its Class A common stock at a price to the public of $80.00 per share)

• $Vidler Water Resouces (VWTR.US)$ +1.4% (announces court decision)

• $3D系统 (DDD.US)$ +1.3% (enters radiation oncology market with FDA 510(k) clearance of VSP Bolus)

• $理想汽车 (LI.US)$ +1% (updates the status under Holding Foreign Companies Accountable Act)

• $The AZEK (AZEK.US)$ +1.8% (upgraded to Buy from Neutral at Citigroup)

• $美国航空 (AAL.US)$ +0.9% (upgraded to Neutral from Underweight at JP Morgan)

• $Gap Inc (GPS.US)$ -16.1% (lowers AprQ revenue guidance; also Old Navy CEO stepping down)

• $Corsair Gaming (CRSR.US)$ -14.8% (guides Q1 revs below consensus)

• $HCA医疗 (HCA.US)$ -12%（earnings report）

• $奥托立夫 (ALV.US)$-8.9%（earnings report）

• $Globus Medical (GMED.US)$ -6.8% (guides QI revs below consensus; also CEO to resign)

• $希尔托普控股 (HTH.US)$ -5.4%（earnings report）

• $Swvl Holdings (SWVL.US)$ -7.3% (stock offering)

• $极光 (JG.US)$ -5% (updates the status under Holding Foreign Companies Accountable Act)

• $美鹰服饰 (AEO.US)$ -2.4% (in sympathy with GPS guidance)

• $ACM Research (ACMR.US)$ -1.8% (moves wafer cleaning tool to mass production)

• $利安德巴塞尔 (LYB.US)$ -1.4% (to cease operation of Houston Refinery by end of 2023)

• $百威英博 (BUD.US)$ -1.3% ( to sell interest in Russian JV)

• $AeroVironment (AVAV.US)$ -2.3% (downgraded to Neutral from Outperform at Robert Baird)